---
$id: https://graph.org.ai/products/commodity/51343810
$type: Product
source: UNSPSC
code: "51343810"
title: "Atazanavir/ritonavir and lamivudine/zidovudine"
class: "51343800"
classTitle: "Combination antivirals"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Atazanavir/ritonavir and lamivudine/zidovudine

**UNSPSC Code**: 51343810
**Class**: [Combination antivirals](Combination antivirals.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug for treatment of HIV. This is for copackaged product. The first component, ATAZANAVIR, has a US FDA Unique Ingredient Identifier of QZU4H47A3S. The second component, RITONAVIR, has a US FDA Unique Ingredient Identifier of O3J8G9O825. The third component, LAMIVUDINE, has US FDA Unique Ingredient Identifier of 2T8Q726O95. The fourth component, ZIDOVUDINE, has US FDA Unique Ingredient Identifier of 4B9XT59T7S.

